IL13Rα2 chimeric antigen receptor T cells combined with checkpoint blockade to treat glioblastoma in human and canine models

被引：0
作者：
Yin, Y. [1 ]
Binder, Z. [1 ]
Thokala, R. [1 ]
O'Rourke, D. [1 ]
机构：
[1] Univ Penn, Neurosurg, Philadelphia, PA 19104 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
151 (PB-00
引用
收藏
页码：E57 / E57
页数：1
相关论文
共 50 条
  • [21] Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
    Kong, Seogkyoung
    Sengupta, Sadhak
    Tyler, Betty
    Bais, Anthony J.
    Ma, Qiangzhong
    Doucette, Saryn
    Zhou, Jinyuan
    Sahin, Ayguen
    Carter, Bob S.
    Brem, Henry
    Junghans, Richard P.
    Sampath, Prakash
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5949 - 5960
  • [22] Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
    Bagley, Stephen J.
    Logun, Meghan
    Fraietta, Joseph A.
    Wang, Xin
    Desai, Arati S.
    Bagley, Linda J.
    Nabavizadeh, Ali
    Jarocha, Danuta
    Martins, Rene
    Maloney, Eileen
    Lledo, Lester
    Stein, Carly
    Marshall, Amy
    Leskowitz, Rachel
    Jadlowsky, Julie K.
    Christensen, Shannon
    Oner, Bike Su
    Plesa, Gabriela
    Brennan, Andrea
    Gonzalez, Vanessa
    Chen, Fang
    Sun, Yusha
    Gladney, Whitney
    Barrett, David
    Nasrallah, MacLean P.
    Hwang, Wei-Ting
    Ming, Guo-Li
    Song, Hongjun
    Siegel, Donald L.
    June, Carl H.
    Hexner, Elizabeth O.
    Binder, Zev A.
    O'Rourke, Donald M.
    NATURE MEDICINE, 2024, 30 (05) : 1320 - +
  • [23] Targeting IL13R alpha2 heterogeneity in malignant glioma with engineered T cells
    Sengupta, Sadhak
    Balyasnikova, Irina
    Naheed, Seema
    Lesniak, Maciej S.
    Junghans, Richard P.
    Sampath, Prakash
    CANCER RESEARCH, 2014, 74 (19)
  • [24] HIGHLY POTENT CYTOTOXIN TARGETING IL-13Rα2 IN CANINE AND HUMAN GLIOBLASTOMA
    Gibo, Denise M.
    Dickinson, Peter
    Robertson, John
    Rossmeisl, John
    Debinski, Waldemar
    NEURO-ONCOLOGY, 2012, 14 : 31 - 32
  • [25] Cell intrinsic PD-1 checkpoint blockade releases the brake on human chimeric antigen receptor (CAR) T cells for solid tumors
    Fraietta, Joseph A.
    Melenhorst, J. Joseph
    Levine, Bruce L.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1328 - S1332
  • [26] Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
    Krenciute, Giedre
    Prinzing, Brooke L.
    Yi, Zhongzhen
    Wu, Meng-Fen
    Liu, Hao
    Dotti, Gianpietro
    Balyasnikova, Irina V.
    Gottschalk, Stephen
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (07) : 571 - 581
  • [27] Bispecific T Cell Engager (BiTE) Targeting IL13Rα2 Improves Survival in a Pre-Clinical Model of Glioblastoma. Bispecific T Cell Engager (BiTE) Targeting IL13Rα2 Improves Survival in a Pre-Clinical Model of Glioblastoma
    Zannikou, Markella
    Pituch, Katarzyna C.
    Ilut, Liliana
    Balyasnikova, Irina V.
    MOLECULAR THERAPY, 2019, 27 (04) : 267 - 267
  • [28] MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors
    An, Wen
    Kang, Ju-Seop
    Oh, Sukjoong
    Tu, Ang
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2023, 27 (03) : 241 - 256
  • [29] ADOPTIVE TRANSFER OF IL13Rα2-SPECIFIC T CELLS FOR THE TREATMENT OF GLIOBLASTOMA: BUILDING ON CLINICAL ACHIEVEMENTS WITH SECOND-GENERATION CARs
    Brown, Christine
    Starr, Renate
    Aguilar, Brenda
    Chang, Brenda
    Sarkissian, Aniee
    Naranjo, Araceli
    Chang, Wen-Chung
    Jensen, Michael
    D'Apuzzo, Massimo
    Barish, Michael
    Badie, Behnam
    Forman, Stephen
    NEURO-ONCOLOGY, 2014, 16
  • [30] Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells
    Krenciute, Giedre
    Prinzing, Brooke
    Yi, Zhongzhen
    Balyasnikova, Irina
    Dotti, Gianpietro
    Gottschalk, Stephen
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S1 - S1
12345